Type 2 Diabetes

Patient support program offers savings on Glumetza therapy for Type 2 diabetes

Published in Healthcare Mergers, Acquisitions and Ventures Week, December 23rd, 2006

King Pharmaceuticals, Inc. (KG) and Depomed, Inc. (DEPO) announced the launch of a program that will provide financial support for patients with diabetes who are receiving treatment with Glumetza (metformin hydrochloride extended-release tablets), a new once-daily extended-release metformin formulation that features AcuForm drug-delivery technology.

"Patients with type 2 diabetes are often using multiple medications to control their blood glucose as well as to manage the co-morbidities associated with diabetes, like high blood pressure and high cholesterol," said Brian A. Markison, president and chief executive officer of King Pharmaceuticals. "We recognize the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week

Source: Healthcare Mergers, Acquisitions and Ventures Week (2006-12-23)

More Articles from Healthcare Mergers, Acquisitions and Ventures Week

Accreditation
BlueCross BlueShield of Tennessee awarded URAC Consumer Education and Support Accreditation
Accreditation
Corphealth receives URAC Health Utilization Management Reaccreditation
Age-Related Macular Degeneration
Novartis gets positive E.U. regulatory opinion on ranibizumab treatment for vision loss
Allergic Rhinitis
China Biopharmaceuticals completes all clinical trials of Desloratadine for hay fever
Alzheimer Disease
Nymox pursuing new approaches to Alzheimer disease
Alzheimer Disease
Prana Biotechnology raises $6 million for Phase IIa clinical trial of PBT2 in Alzheimer disease
More from this issue of Healthcare Mergers, Acquisitions and Ventures Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry